Former PR agent Wendell Potter's stories of how he helped the health insurance's industry's campaign "to discredit Michael Moore and his film Sicko" calls to mind just how successful that campaign was. Corporate media coverage of the debate raised by the film's expose of the for-profit insurance system went out of its way to demonize Moore. USA Today ran an editorial tied to the film against a single-payer healthcare plan, which was paired with an "Opposing View" from an insurance executive that denounced single-payer even more harshly. CBS News' Jeff Greenfield distinguished himself with his (inaccurate) claim that the U.S. doesn't have public funding for healthcare because "Americans are just different." And reviewing CNN's report on Sicko can only make one relieved that Sanjay Gupta turned down the job of surgeon general.

If you'd like to see an end to this kind of insurance industry PR masquerading as journalism, you can sign FAIR's petition calling for the inclusion of the single-payer option in coverage of the healthcare reform debate.

Stating that "a lot of funny things can happen when the media translate science for the public," science writer Chris Mooney (Nation, 3/6/09) looks over more evidence that the U.S. public got really lucky when CNN's Sanjay Gupta was not made Obama's surgeon general. Mooney's list of Gupta "approaching medical coverage through 'one the one hand, on the other hand' equivocation, the selling of medical entertainment, following the pack or simply getting it wrong" clearly illustrates "what always made Gupta's nomination worrisome":

Consider a few of Gupta's journalistic missteps. In late December 2002--a slow news week after Christmas--an outfit named Clonaid, run by a member of a UFO-obsessed group called the Raelians, decided to hold a press conference announcing the first cloning of a human being. The media responded like a herd and ran off a cliff. Many outlets, including CNN, covered the group's press conference live, even though numerous scientists and bioethicists could have told them the claim wasn't credible. Yet there was Gupta, breathlessly interviewing Clonaid's "clinical science director" about "the possibility, a big possibility, that a human clone was actually born." Gupta and CNN contributed heavily to a media scare with little foundation; to this day, we've never seen proof of the existence of baby "Eve."

And of course Mooney features Gupta's infamous "'reality check' on Michael Moore's 2007 film SiCKO"; see the FAIR Action Alert: "CNN vs. SiCKO" (7/11/07).

Los Angeles Times reporter Mike Dorning has some important information (3/6/09) absent from coverage of Dr. Sanjay Gupta's recent surgeon general candidacy--"For several years, Gupta has been co-anchor of a CNN-produced healthcare show distributed monthly via flat-screen TVs provided free to doctor's offices":

The show is sponsored by healthcare, consumer and pharmaceutical companies that want to get their message directly to patients, according to the website of AccentHealth, a privately held company that distributes the programs and sells them to advertisers.

Dr. Quentin Young--who heads Physicians for a National Health Program, a group that advocates for single-payer, Canadian-style national health insurance and other changes in the present system--and other critics cited occasions when Gupta favorably mentioned sponsors' brand-name drugs.

"His record is not a good one here," Young said.

While Dorning gives space to such unsupported CNN platitudes as "Gupta's on-air comments had always been under the editorial control of CNN and unrelated to any advertising contracts" and "Dr. Gupta has no relationship with the advertisers of the program--monetarily, editorially or otherwise," regular FAIR readers have known of Gupta's untrustworthiness for years; for more critique of CNN's medical coverage, see our current Action Alert: "CNN: Single-Payer Is So '90s: Medical Reporter Warns Against 'Government-Run Health System'" (3/12/09)

Another problem with getting your surgeon general pick from corporate media is that they're likely to have corporate media's typical biases against marijuana.